An international randomized cross-over bio-equivalence study of oral paclitaxel 1 HM30181 compared with weekly intravenous (IV) paclitaxel in patients with advanced solid tumours

C G C A Jackson, S Deva, K Bayston, B Mclaren, P Barlow, Noelyn Anne Hung, K Clarke, Eva Segelov, T.-Y Chao, M.-S Dai, H. -T Yen, D Cutler, J Zhi, W.-K Chan, M.-F R Kwan, C - T Hung

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Number of pages2
JournalAnnals of Oncology
Volume30
Issue numberSupp 5
DOIs
Publication statusPublished - Oct 2019
EventESMO Congress (ESMO) 2019 - Barcelona, Spain
Duration: 27 Sep 20191 Oct 2019
Conference number: 44th

Cite this